Skip to main content
Smart Investors Daily
MR

OTC · MRAI

Marpai, Inc.

Healthcare · Medical - Healthcare Plans

$3.22

Up+$0.13 (+4.21%)

Updated Sep 20, 2026, 3:30 AM

SID Score

4.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
12.31M
P/E ratio
-1.02
Dividend yield
0.00%
52-week range
— – —
Volume
11.66K
Avg. volume
22.92K

Price performance

MRAI price history

1M range · 0 trading sessions · Daily adjusted prices

MRAI does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest MRAI news

The latest Smart Investors Daily articles mentioning MRAI.

MRAI research

Overview

Company profile and research snapshot.

Company profile

MARPAI INC A

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$6.00
Implied upside
Analysts
MRAI recent ratings
DateFirmRatingTarget
Mar 28, 2024Maxim GroupBuy
Nov 15, 2023Maxim GroupHold
Nov 14, 2023Maxim GroupHold
Aug 1, 2022Maxim GroupBuy
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Dec 1, 2025

MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION

Marpai Inc. reports strong sales momentum for 2026, renewing its Aetna Signature Administrator network agreement and integrating the Faircost Optimizer to enhance cost management for self-funded employer health plans.

Yahoo · Dec 1, 2025

MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION

Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced significant positive momentum heading into the new year, highlighted by a better-than-expected sales cycle for 2026 and the renewal of its critical network access agreement with Aetna.

seekingalpha.com · Nov 13, 2025

Marpai, Inc. (MRAI) Q3 2025 Earnings Call Transcript

Marpai, Inc. (OTCQX:MRAI) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants Steve Johnson - CFO & Company Secretary Damien Lamendola - CEO & Director Dallas Scrip - President & COO Presentation Operator Good morning, and welcome to Marpai Third Quarter 2025 Earnings Webcast. [Operator Instructions] Please note that this conference is being recorded.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.